Modeling Immune Checkpoint Inhibitor Efficacy in Syngeneic Mouse Tumors in an Ex Vivo Immuno-Oncology Dynamic Environment

The immune checkpoint blockade represents a revolution in cancer therapy, with the potential to increase survival for many patients for whom current treatments are not effective. However, response rates to current immune checkpoint inhibitors vary widely between patients and different types of cance...

Descripción completa

Detalles Bibliográficos
Autores principales: Doty, Daniel T., Schueler, Julia, Mott, Vienna L., Bryan, Cassie M., Moore, Nathan F., Ho, John C., Borenstein, Jeffrey T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7555450/
https://www.ncbi.nlm.nih.gov/pubmed/32899865
http://dx.doi.org/10.3390/ijms21186478

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7555450/
https://www.ncbi.nlm.nih.gov/pubmed/32899865
http://dx.doi.org/10.3390/ijms21186478

Ejemplares similares